pool adsPdl Biopharma $PGJ Technical Update
The Pdl Biopharma (NYSE: PGJ) update and the technical summary table below can help you manage risk and optimize returns. We have day, swing, and longer-term trading plans for PGJ, and 1300 other stocks too, updated in real time for our trial subscribers. The data below is a snapshot, but updates are available now.
Technical Summary
| Term → | Near | Mid | Long |
|---|---|---|---|
| Rating | Neutral | Weak | Neutral |
| P1 | 36.69 | 34.77 | 36.61 |
| P2 | 37.38 | 37.27 | 41.92 |
| P3 | 38.27 | 39.68 | 47.04 |
Support and Resistance Plot Chart for PGJ
Long Term Trading Plans for PGJ
September 19, 2018, 6:15 am ET
The Technical Summary and Trading Plans for PGJ help you determine where to buy, sell, and set risk controls. The data is best used in conjunction with our Market Analysis and Stock Correlation Filters too, because those help us go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis with this PGJ Report.
PGJ - (Long) Support Plan
Buy over 36.61 target 41.92 stop loss @ 36.35.
The technical summary data tells us to buy PGJ near 36.61 with an upside target of 41.92. This data also tells us to set a stop loss @ 36.35 to protect against excessive loss in case the stock begins to move against the trade. 36.61 is the first level of support below 37.15 , and by rule, any test of support is a buy signal. In this case, support 36.61 would be being tested, so a buy signal would exist.
PGJ - (Short) Resistance Plan
Short under 41.92 target 36.61 stop loss @ 42.18.
The technical summary data is suggesting a short of PGJ as it gets near 41.92 with a downside target of 36.61. We should have a stop loss in place at 42.18 though. 41.92 is the first level of resistance above 37.15, and by rule, any test of resistance is a short signal. In this case, if resistance 41.92 is being tested, so a short signal would exist.
